278 related articles for article (PubMed ID: 30738186)
1. Tuberculin skin test - Outdated or still useful for Latent TB infection screening?
Gualano G; Mencarini P; Lauria FN; Palmieri F; Mfinanga S; Mwaba P; Chakaya J; Zumla A; Ippolito G
Int J Infect Dis; 2019 Mar; 80S():S20-S22. PubMed ID: 30738186
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
So H; Yuen CS; Yip RM
Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
[TBL] [Abstract][Full Text] [Related]
5. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
6. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
[TBL] [Abstract][Full Text] [Related]
9. Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.
Sousa S; Rocha D; Silva JC; Ribeiro AI; Gonçalves G; Almeida Á; Correia AM; Duarte R; Carvalho C
Pulmonology; 2021; 27(6):493-499. PubMed ID: 34053903
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
11. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
[TBL] [Abstract][Full Text] [Related]
12. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
Binay UD; Fincancı M; Fersan E; Karakeçili F
Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
[TBL] [Abstract][Full Text] [Related]
14. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
[TBL] [Abstract][Full Text] [Related]
16. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
17. Tests for latent tuberculosis in people with ESRD: a systematic review.
Rogerson TE; Chen S; Kok J; Hayen A; Craig JC; Sud K; Kable K; Webster AC
Am J Kidney Dis; 2013 Jan; 61(1):33-43. PubMed ID: 23068425
[TBL] [Abstract][Full Text] [Related]
18. Position statement on interferon-γ release assays for the detection of latent tuberculosis infection.
Bastian I; Coulter C;
Commun Dis Intell Q Rep; 2017 Dec; 41(4):E322-E336. PubMed ID: 29864386
[TBL] [Abstract][Full Text] [Related]
19. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
El-Helaly M; Khan W; El-Saed A; Balkhy HH
J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
[TBL] [Abstract][Full Text] [Related]
20. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
